Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × Alemtuzumab × Clear all

NCT00281983 2017-07-24

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell